KNSA - Kiniksa Pharmaceuticals International Plc Forecast, Target Price

Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: PRGO OGN MNKD AMPH PCRX

| Held by: VTI VB VBK DFAS DFMC DFAC VHT FFTY FESM FDLS

Scroll to Statements

Index	-	P/E	64.51	EPS (ttm)	0.91	Insider Own	42.48%	Shs Outstand	46.05M	Perf Week	2.83%
Market Cap	4.50B	Forward P/E	30.91	EPS next Y	1.89	Insider Trans	-2.48%	Shs Float	44.25M	Perf Month	27.57%
Enterprise Value	4.04B	PEG	0.63	EPS next Q	0.30	Inst Own	59.99%	Short Float	7.98%	Perf Quarter	30.93%
Income	73.06M	P/S	5.97	EPS this Y	82.96%	Inst Trans	8.89%	Short Ratio	4.84	Perf Half Y	44.29%
Sales	754.04M	P/B	7.41	EPS next Y	38.00%	ROA	10.26%	Short Interest	3.53M	Perf YTD	41.92%
Book/sh	7.90	P/C	9.62	EPS next 5Y	49.30%	ROE	13.74%	52W High	59.87 -2.22%	Perf Year	133.88%
Cash/sh	6.08	P/FCF	27.42	EPS past 3/5Y	-34.04% -	ROIC	11.95%	52W Low	24.85 135.57%	Perf 3Y	328.86%
Dividend Est.	-	EV/EBITDA	42.63	Sales past 3/5Y	45.45% -	Gross Margin	54.61%	Volatility	3.20% 4.48%	Perf 5Y	314.30%
Dividend TTM	-	EV/Sales	5.36	EPS Y/Y TTM	509.31%	Oper. Margin	12.36%	ATR (14)	2.21	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.33	Sales Y/Y TTM	56.71%	Profit Margin	9.69%	RSI (14)	69.10	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	3.79	EPS Q/Q	144.51%	SMA20	12.38%	Beta	0.18	Target Price	63.50
Payout	0.00%	Debt/Eq	0.01	Sales Q/Q	55.51%	SMA50	19.87%	Rel Volume	0.55	Prev Close	59.12
Employees	366	LT Debt/Eq	0.01	Earnings	Apr 28 BMO	SMA200	40.17%	Avg Volume	729.81K	Price	58.54
IPO	May 24, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	33.80% 3.96%	Trades		Volume	409,673	Change	-0.98%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)